Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 84.55% institutional investors, 0.32% insiders, and 15.13% retail investors. Capital world investors is the largest institutional shareholder, holding 10.98% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 3.65% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals84.55%0.32%15.13%
SectorHealthcare Stocks 57.00%9.27%33.74%
IndustryBiotech Stocks 68.69%8.88%22.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors28.33M10.98%$11.41B
Vanguard group23.26M9.01%$9.37B
Blackrock funding, inc. /de21.83M8.46%$8.79B
Blackrock21.31M8.25%$9.99B
State street11.73M4.54%$5.50B
Capital research global investors10.43M4.04%$4.20B
Fmr9.22M3.57%$3.71B
Jpmorgan chase6.31M2.45%$2.54B
Wellington management group llp5.92M2.29%$2.38B
Geode capital management5.65M2.19%$2.27B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Bridger management41.05K8.88%$16.53M
Provident investment management155.07K5.96%$62.45M
Montchanin asset management10.74K4.76%$5.03M
Bellevue group487.43K3.78%$196.29M
Healthinvest partners ab22.26K3.60%$7.60M
Edgewood management2.96M3.42%$1.19B
Guoline advisory pte79.70K3.31%$32.10M
Birch hill investment advisors172.82K3.24%$69.60M
Pfm health sciences, lp126.99K3.17%$51.14M

Top Buyers

HolderShares% AssetsChange
Norges bank3.41M0.18%3.41M
Parnassus investments1.82M1.62%1.82M
Capital world investors28.33M1.73%1.51M
Capital research global investors10.43M0.86%1.43M
Edgewood management2.96M3.42%1.41M

Top Sellers

HolderShares% AssetsChange
Alliancebernstein3.92M0.54%-3.45M
Fmr9.22M0.22%-1.31M
Jennison associates4.32M1.06%-1.23M
Blackrock21.31M0.23%-648.44K
Massachusetts financial services co /ma/2.29M0.29%-617.21K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.41M0.18%3.41M$1.37B
Parnassus investments1.82M1.62%1.82M$731.28M
Wcm investment management1.09M1.03%1.09M$435.90M
Raymond james financial471.91K0.07%471.91K$190.04M
Capital investors342.51K0.03%342.51K$137.93M

Sold Out

HolderChange
Mcclarren financial advisors-1.00
Mine & arao wealth creation & management, llc.-1.00
Tfo-tdc-2.00
Proffitt & goodson-4.00
Triad wealth partners-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241,444-9.69%218,148,736-5.74%841.05%664-9.78%543-5.89%
Sep 30, 20241,575-1.25%231,077,223-1.65%891.08%726-11.68%56810.29%
Jun 30, 20241,5701.88%234,312,9101.05%901.13%8135.31%505-1.17%
Mar 31, 20241,5413.35%231,875,378-1.27%891.08%772-2.77%5116.24%
Dec 31, 20231,49112.02%234,856,0361.31%911.13%79427.65%4817.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A9.40M3.65%1.30M
Capital Group Growth Fnd of Amer Comp9.40M3.65%1.30M
Vanguard Total Stock Mkt Idx Inv8.09M3.15%21.73K
Vanguard Institutional 500 Index Trust7.09M2.76%118.67K
Invesco QQQ Trust5.36M2.09%71.06K
American Funds American Balanced A4.93M1.91%-55.00K
American Funds New Perspective A4.03M1.56%345.03K
Capital Group New Perspective Comp4.03M1.56%345.03K
Fidelity Contrafund3.25M1.26%-183.00K
SPDR® S&P 500® ETF Trust3.21M1.25%12.84K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 27, 2025Tatsis Ourania EVP, Chief Reg. & Quality Off.Sell$251.93K
Feb 27, 2025Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.Sell$1.26M
Feb 27, 2025ALTSHULER DAVID EVP, Chief Scientific OfficerSell$610.56K
Feb 25, 2025Tatsis Ourania EVP, Chief Reg. & Quality Off.Sell$170.26K
Feb 25, 2025Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.Sell$849.84K

Insider Transactions Trends


DateBuySell
2025 Q1-15
2024 Q4-4
2024 Q3-9
2024 Q2-17
2024 Q1-30

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 84.55%, followed by 0.32% insiders and 15.13% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 68.69%, which Vertex Pharmaceuticals exceeds.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (28.33M shares, 10.98%), Vanguard group (23.26M shares, 9.01%), and Blackrock funding, inc. /de (21.83M shares, 8.46%). Together, they hold 28.45% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 3.65% of its total shares outstanding invested in 9.4M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools